Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

被引：0
|
作者：
Hiroko Masuda
Norikazu Masuda
Yoshinori Kodama
Masami Ogawa
Michiko Karita
Jun Yamamura
Kazunori Tsukuda
Hiroyoshi Doihara
Shinichiro Miyoshi
Masayuki Mano
Shoji Nakamori
Toshimasa Tsujinaka
机构：
[1] National Hospital Organization Osaka National Hospital,Department of Surgery
[2] National Hospital Organization Osaka National Hospital,Department of Pathology
[3] Okayama University Graduate School of Medicine,Department of Cancer and Thoracic Surgery
[4] Dentistry and Pharmaceutical Sciences,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Triple-negative breast cancer; Neoadjuvant chemotherapy; Pathological complete response; Ki-67; Basal-like phenotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：911 / 917
页数：6
相关论文
共 50 条
  • [21] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [22] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [23] Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
    Li, Zhijun
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [24] Predictive Factors and Patterns of Recurrence in Patients With Triple-Negative Breast Cancer
    Steward, Lauren
    Conant, Leah
    Gao, Feng
    Margenthaler, Julie A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 109 - 109
  • [25] TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer
    Wang, Kaijing
    Chai, Jia
    Xu, Junpeng
    Wei, Jie
    Li, Peifeng
    Liu, Yixiong
    Ma, Jing
    Xu, Tianqi
    Zhao, Danhui
    Yu, Kangjie
    Fan, Linni
    Yan, Qingguo
    Guo, Shuangping
    Li, Mingyang
    Wang, Zhe
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 226
  • [26] Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
    Ruo-Xi Wang
    Sheng Chen
    Liang Huang
    Zhi-Ming Shao
    BMC Cancer, 18
  • [27] Predictive and prognostic value of Matrix metalloproteinase (MMP)-9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
    Wang, Ruo-Xi
    Chen, Sheng
    Huang, Liang
    Shao, Zhi-Ming
    BMC CANCER, 2018, 18 : 1 - 8
  • [28] Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients
    Cavallone, Luca
    Adriana, Aguilar-Mahecha
    Aldamry, Mohammed
    Lafleur, Josianne
    Cathy, Lan
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Mihalciou, Catalin
    Roy, Josee-Anne
    Markus, Elisabeth
    Robidoux, Andre
    Pelmus, Manuela
    Aleynikova, Olga
    Discepola, Federico
    Basik, Mark
    CANCER RESEARCH, 2018, 78 (04)
  • [29] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    BIOSCIENCE REPORTS, 2019, 39
  • [30] Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer
    Connor, Carol S.
    Kimler, Bruce
    Mammen, Joshua M.
    McGinness, Marilee K.
    Wagner, Jamie L.
    Alsop, Samantha M.
    Ward, Claire
    Fabian, Carol
    Khan, Qamar
    Sharma, Priyanka
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 38 - 39
12345